Performance of the revised 2016 fibromyalgia diagnostic criteria in Korean patients with fibromyalgia

Aim Recently, the revised 2016 version of the 2010/2011 fibromyalgia (FM) criteria was released. No study has yet assessed whether the 2016 criteria perform better than the previous criteria. Therefore, we validated a Korean version of the revised FM criteria and explored whether they were better th...

Full description

Saved in:
Bibliographic Details
Published in:International journal of rheumatic diseases 2019-09, Vol.22 (9), p.1734-1740
Main Authors: Kang, Ji‐Hyoun, An, Minjeong, Choi, Sung‐Eun, Xu, Haimuzi, Park, Dong‐Jin, Lee, Jung‐Kil, Lee, Shin‐Seok
Format: Article
Language:English
Subjects:
Adult
Arthritis
Case-Control Studies
Cost of Illness
diagnostic criteria
Female
Fibromyalgia
Fibromyalgia - diagnosis
Fibromyalgia - epidemiology
Health Status
Humans
Male
Middle Aged
Osteoarthritis
Pain
Predictive Value of Tests
Questionnaires
reliability
Reproducibility of Results
Republic of Korea - epidemiology
Rheumatoid arthritis
School boards
Severity of Illness Index
Surveys and Questionnaires
Systemic lupus erythematosus
Textbooks
validity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim Recently, the revised 2016 version of the 2010/2011 fibromyalgia (FM) criteria was released. No study has yet assessed whether the 2016 criteria perform better than the previous criteria. Therefore, we validated a Korean version of the revised FM criteria and explored whether they were better than the previous criteria in terms of diagnostic accuracy. Methods We enrolled 86 FM patients and 89 patients with various rheumatological disorders, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and myofascial pain syndrome. All patients were invited to complete a questionnaire that included the revised Fibromyalgia Impact Questionnaire (FIQ), the EuroQol five‐dimensional questionnaire (EQ‐5D), and the Multidimensional Health Assessment Questionnaire (MD‐HAQ). Results The test‐retest reliability of the revised criteria was assessed in 30 patients after 2 weeks; the Spearman coefficient ranged from 0.616 to 0.910 and the Cronbach's alpha was 0.942 (95% CI: 0.930‐0.964). The revised criteria correlated significantly with the revised FIQ score (P 
ISSN:1756-1841
1756-185X
DOI:10.1111/1756-185X.13661